依托红霉素结构式
|
常用名 | 依托红霉素 | 英文名 | Erythromycin Estolate |
---|---|---|---|---|
CAS号 | 3521-62-8 | 分子量 | 1000.324 | |
密度 | 1.0053 (rough estimate) | 沸点 | 827.7ºC at 760 mmHg | |
分子式 | C52H97NO18S | 熔点 | 135-140ºC dec. | |
MSDS | 中文版 美版 | 闪点 | 454.4ºC | |
符号 |
GHS07, GHS08 |
信号词 | Danger |
依托红霉素用途Erythromycin estolate 是红霉素衍生物,是一种大环内酯类抗生素,用于治疗多种细菌感染。Erythromycin estolate 引起数例肝损伤,主要包括胆汁淤积性肝炎。Erythromycin estolate 的毒性与其对胆汁酸运输的抑制作用有关。 |
中文名 | 无味红霉素 |
---|---|
英文名 | erythromycin estolate |
中文别名 | 红霉素丙酸酯十二烷基硫酸盐 | 依托红霉素 | 依托红霉素 | 红霉素月桂酸酯 |
英文别名 | 更多 |
描述 | Erythromycin estolate 是红霉素衍生物,是一种大环内酯类抗生素,用于治疗多种细菌感染。Erythromycin estolate 引起数例肝损伤,主要包括胆汁淤积性肝炎。Erythromycin estolate 的毒性与其对胆汁酸运输的抑制作用有关。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.0053 (rough estimate) |
---|---|
沸点 | 827.7ºC at 760 mmHg |
熔点 | 135-140ºC dec. |
分子式 | C52H97NO18S |
分子量 | 1000.324 |
闪点 | 454.4ºC |
精确质量 | 999.616394 |
PSA | 271.96000 |
LogP | 7.55400 |
外观性状 | 长针状 |
折射率 | 1.6550 (estimate) |
储存条件 | -20°C Freezer |
水溶解性 | chloroform: soluble4.0ML, clear, colorless (200 mg + 4.0 mL Chloroform) |
符号 |
GHS07, GHS08 |
---|---|
信号词 | Danger |
危害声明 | H302-H317-H334 |
警示性声明 | P261-P280-P342 + P311 |
危害码 (欧洲) | Xn:Harmful |
风险声明 (欧洲) | R22;R42/43 |
安全声明 (欧洲) | S22-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | KF5775000 |
海关编码 | 29419000 |
~% 依托红霉素 3521-62-8 |
文献:Skin Pharmacology, , vol. 8, # 6 p. 319 - 325 |
依托红霉素上游产品 2 | |
---|---|
依托红霉素下游产品 0 |
Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats.
J. Ethnopharmacol. 57(3) , 161-7, (1997) Livex, a compound herbal formulation, was investigated for its possible hepatoprotective effect in Wistar rats against erythromycin estolate induced toxicity. Oral administration of Livex significantl... |
|
Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
J. Colloid. Interface Sci. 271(2) , 336-41, (2004) In this work, the producing of a biodegradable poly(l-lactide) (PLA)/poly(ethylene glycol) (PEG) microcapsule by emulsion solvent evaporation method was investigated. The effect of PEG segments added ... |
|
Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals.
Am. J. Vet. Res. 61(8) , 914-9, (2000) To determine pharmacokinetics and plasma concentrations of erythromycin and related compounds after intragastric administration of erythromycin phosphate and erythromycin estolate to healthy foals.11 ... |
Erythromycin Estolate |
Erythromycin 2'-propionate dodecyl sulfate |
Erythromycin 2′-propionate dodecyl sulfate |
Dodecyl hydrogen sulfate - (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (1:1) |
Erythromycin 2-Propionate Dodecyl Sulfate |